REQUEST A DEMO
Total
USD $0.00
Search more companies

Biotech S.A.S. B.I.C (Colombia)

Main Activities: Machinery, Equipment, and Supplies Merchant Wholesalers
Full name: Biotech S.A.S. B.I.C Profile Updated: April 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Biotech S.A.S. B.I.C is a company in Colombia, with a head office in Bucaramanga. The company operates in the Machinery, Equipment, and Supplies Merchant Wholesalers sector. The enterprise was incorporated on October 27, 1997. 4 (2024) employees currently work for Biotech S.A.S. B.I.C. The latest financial highlights indicate a net sales revenue drop of 57.55% in 2023. Its’ total assets recorded a growth of 13.96%. The net profit margin of Biotech S.A.S. B.I.C decreased by 1.85% in 2023.

Headquarters
Carrera 31 # 14 - 58 Carrera
Bucaramanga; Santander;

Contact Details: Purchase the Biotech S.A.S. B.I.C report to view the information.

Basic Information
Total Employees:
Purchase the Biotech S.A.S. B.I.C report to view the information.
Outstanding Shares:
Purchase the Biotech S.A.S. B.I.C report to view the information.
Registered Capital:
Purchase the Biotech S.A.S. B.I.C report to view the information.
Incorporation Date:
October 27, 1997
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Biotech S.A.S. B.I.C report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-57.55%
Total operating revenue
-57.76%
Net Profit (Loss) for the Period
-81.34%
Total assets
13.96%
Total equity
1.85%
Net Profit Margin
-1.85%
Return on Equity (ROE)
-8.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?